|
Post by JHam on Sept 29, 2015 0:24:18 GMT
Bought some shares at $2.31 We are at a 52 week low. The volume is just about twice the average daily volume but the stock has tanked about 17%. I think the drop is too step for such a low volume. The drop is most likely related to CEO's departure. Plan to keep adding more if this one falls further. Nice buy. It seems like today any reason for a drop was multiplied by 10 in biotech. What a blood bath. Black Monday, lol. Was a good day for buying bargain shares in my opinion.
|
|
|
Post by dayanand33 on Sept 29, 2015 18:41:10 GMT
Bought some shares at $2.31 We are at a 52 week low. The volume is just about twice the average daily volume but the stock has tanked about 17%. I think the drop is too step for such a low volume. The drop is most likely related to CEO's departure. Plan to keep adding more if this one falls further. Nice buy. It seems like today any reason for a drop was multiplied by 10 in biotech. What a blood bath. Black Monday, lol. Was a good day for buying bargain shares in my opinion. another 52 week low today. Added some more at $2.22 . Hope I am not catching a falling knife :-)
|
|
|
Post by JHam on Sept 29, 2015 18:45:05 GMT
Nice buy. It seems like today any reason for a drop was multiplied by 10 in biotech. What a blood bath. Black Monday, lol. Was a good day for buying bargain shares in my opinion. another 52 week low today. Added some more at $2.22 . Hope I am not catching a falling knife :-) Yeah it is nuts right now. I almost feel like going 100% cash and waiting for this all to settle down.
|
|
|
Post by dayanand33 on Oct 5, 2015 16:38:25 GMT
Sold 1/3 position for about 13% profit. Hate to sell it but learning to take profits as they come by.
|
|
|
Post by dayanand33 on Oct 7, 2015 15:24:34 GMT
|
|
|
Post by dayanand33 on Oct 7, 2015 17:01:58 GMT
sold all my remaining position at about 16 profit. Will buy back if it retraces
|
|
|
Post by JHam on Dec 2, 2015 17:12:30 GMT
BrainStorm Hosting Conference Call to Update Shareholders on Important Developments HACKENSACK, N.J. and PETACH TIKVAH, Israel, Dec. 2, 2015 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that it will hold a conference call on Wednesday, December 16, 2015 at 8:45 a.m. Eastern Standard Time (EST), 15:45 Israel Standard Time (IST). Mr. Chaim Lebovits, BrainStorm's President and Chief Executive Officer will provide an update to shareholders and discuss important company developments. BrainStorm Cell Therapeutics The call will be conducted in English. Callers may participate in the conference call by dialing: USA: 1-888-668-9141 Canada: 1-866-485-2399 Israel: 1-800-227-297 A recording of the conference call will be posted by December 22, 2015 on the company's website: www.brainstorm-cell.comAbout BrainStorm Cell Therapeutics Inc. BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company holds the rights to develop and commercialize its NurOwn® technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University. NurOwn® has been administered to over 60 patients with ALS in clinical trials conducted in Israel and the United States, and is currently being studied in a randomized, double-blind, placebo-controlled clinical trial at three major clinical centers in the United States. For more information, visit the Company's website at www.brainstorm-cell.com. Safe Harbor Statement Statements in this announcement other than historical data and information constitute "forward-looking statements" and involve risks and uncertainties that could cause BrainStorm Cell Therapeutics Inc.'s actual results to differ materially from those stated or implied by such forward-looking statements. Terms and phrases such as "may", "should", "would", "could", "will", "expect", "likely", "believe", "plan", "estimate", "predict", "potential", and similar terms and phrases are intended to identify these forward-looking statements. The potential risks and uncertainties include, without limitation, risks associated with BrainStorm's limited operating history, history of losses; minimal working capital, dependence on its license to Ramot's technology; ability to adequately protect the technology; dependence on key executives and on its scientific consultants; ability to obtain required regulatory approvals; and other factors detailed in BrainStorm's annual report on Form 10-K and quarterly reports on Form 10-Q available at www.sec.gov. These factors should be considered carefully, and readers should not place undue reliance on BrainStorm's forward-looking statements. These forward-looking statements are based on the beliefs, expectations and opinions of management as of the date of this press release. We do not assume any obligation to update forward-looking statements to reflect actual results or assumptions if circumstances or management's beliefs, expectations or opinions should change, unless otherwise required by law. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.. CONTACTS: Uri Yablonka Chief Operating Officer BRAINSTORM CELL THERAPEUTICS INC. 201-488-0460 uri@brainstorm-cell.com Logo - photos.prnewswire.com/prnh/20141006/150511This information is being sent to you by: BrainStorm Cell Therapeutics Inc. 605 THIRD AVENUE, 34TH FLOOR, NEW YORK, NY, 10158, United States www.brainstorm-cell.com If you would like to stop receiving these types of messages from us, you can unsubscribe at any time.
|
|
|
Post by JHam on Dec 2, 2015 17:14:54 GMT
Perhaps there will be a nice run up prior to the call?
|
|
|
Post by Yelk on Dec 5, 2015 23:47:18 GMT
Day trading I trade hundreds of tickers and this came across my radar. Maxim had a bullish article and some crazy price target buy on this few days ago and it did it's typical pop and fade. Had some volume on December 4 after the pull back on Dec 2 news. I think this is smart money buying for run-up and possibly 2016 calalysts. The chart looks very attractive. As you'll notice the huge biotech pullback isn't far off from current 2.50ish support. When trading I use volume resistance a lot.
The chart/action/catalysts suggests next week unnoticed ramp to 3.20s and a breakout towards 4 and honestly even 5. It's been a whole year since this ran and there is some smart people very bullish on it. I haven't done any DD on this in 6 months so I will review a tad tonight.
My plan is to monitor $3 area possibly start a tiny and add dips to a winner. If it did go up considerably I doubt i'd hold hardly any through the conference though as they said important news, not whether it was good or bad. Feel free to share recent DD findings and other ideas.
I'd also like to note more eyes have shifted here after CUR's collapse.
|
|
|
Post by selluwud on Dec 10, 2015 13:54:17 GMT
What do you think this means? "BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that it has rescheduled its conference call, originally scheduled for Wednesday, December 16, 2015 to Monday, January 11, 2016, due to longer than expected embargo on one of the important items to be discussed on the call." Is someone healed? or has a subject died? from: finance.yahoo.com/news/brainstorm-reschedules-corporate-conference-call-124500920.html
|
|
|
Post by dayanand33 on Dec 10, 2015 14:56:39 GMT
Could be a bullish indicator. . I follow other stem cells cos like CUR where patients have died during the course of trial. But companies usually don't hold a cc to announce it. I think it could be that some big fish is interested in taking a stake in the company. The negotiations are taking a little longer and hence the delay in the announcement - IMHO
|
|
|
Post by dayanand33 on Dec 16, 2015 17:17:15 GMT
opened a small position wanting to bet on the Jan 11th news.
|
|
|
Post by JHam on Dec 16, 2015 17:38:18 GMT
opened a small position wanting to bet on the Jan 11th news. Thanks for reminding me about this. Hopefully I can get in prior to any kind of runup.
|
|
|
Post by dayanand33 on Dec 21, 2015 20:15:05 GMT
|
|
|
Post by dayanand33 on Dec 22, 2015 15:51:03 GMT
|
|
|
Post by JHam on Dec 23, 2015 12:14:15 GMT
How do you know they weren't tax related?
|
|
|
Post by dayanand33 on Dec 23, 2015 16:19:22 GMT
|
|
|
Post by JHam on Dec 24, 2015 14:44:22 GMT
Maybe they are selling before a good announcement on the call in January to avoid looking suspicious...
|
|
|
Post by dayanand33 on Dec 24, 2015 18:58:10 GMT
Maybe they are selling before a good announcement on the call in January to avoid looking suspicious... I hope you are right because I am betting on some good news here. It still puzzles me why Florino was let go as CEO. He is well qualified and was doing a decent job leading the company. I am tempted to speculate JV with BP but I am not in any palace ;-)
|
|
|
Post by JHam on Dec 25, 2015 0:24:09 GMT
Maybe they are selling before a good announcement on the call in January to avoid looking suspicious... I hope you are right because I am betting on some good news here. It still puzzles me why Florino was let go as CEO. He is well qualified and was doing a decent job leading the company. I am tempted to speculate JV with BP but I am not in any palace ;-) If it were a JV though they wouldn't be able to sit on that news for so long.
|
|